Physician profile
Rhian Elizabeth Davies
NPI 1174899702
$853,047.54
in general payments reported to CMS, 2019-2025
34 companies · $337K in 2025
The $337K reported for 2025 was more than what 99% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,629 · 2020: $255 · 2021: $17K · 2022: $121K · 2023: $146K · 2024: $224K · 2025: $337K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $291K · Consulting Fee: $123K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $95K · Travel and Lodging: $76K · Honoraria: $73K · Food and Beverage: $49K · Education: $6.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $290,975.83 |
| Consulting Fee | $123,487.50 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $94,850.00 |
| Travel and Lodging | $76,358.04 |
| Honoraria | $72,675.83 |
| Food and Beverage | $48,671.52 |
| Education | $6.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $253,990.86 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Teleflex LLC | $130,832.82 | 2022-2025 | Guideliner, Guideliner V3 Catheter, Turnpike |
| Boston Scientific Corporation | $121,811.42 | 2019-2025 | General - Vascular Access, Avvigo Guidance System, General - Balloons |
| Medtronic, INC. | $118,809.58 | 2021-2025 | Onyx Frontier, Resolute Onyx, Symplicity G3 |
| Abiomed | $91,731.65 | 2022-2025 | Impella |
| Siemens Medical Solutions USA, INC. | $40,673.53 | 2019-2023 | Artis Zeego |
| Arrow International, INC. | $29,518.89 | 2024 | Guideliner, Turnpike |
| Asahi Intecc USA, INC. | $24,420.77 | 2019-2025 | Asahi Ptca Guide Wire, Peripheral Vascular, Asahi Coronary Wires |
| Terumo Medical Corporation | $20,796.77 | 2022-2025 | Glidewire, Metacross Otw, Glidesheath Slender |
| Cordis US Corp. | $13,333.12 | 2023-2025 | Selution Slr Pta, Mynx Venous Vcd, Mynx Control |
| Biotronik INC. | $2,961.90 | 2022-2024 | Nhancer Rx, Trapit, Recross |
| Abbott Laboratories | $982.52 | 2021-2025 | Dragonfly Opstar, Xience Sierra |
| Verge Medical, INC. | $456.08 | 2024 | |
| Heartflow, INC. | $350.00 | 2025 | |
| W. L. Gore & Associates, INC. | $294.18 | 2022-2023 | Gore Cardioform Septal Occluder |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex Medical Canada INC. | $289.56 | 2024 | Turnpike |
| Asahi Intecc Co., Ltd. | $285.33 | 2019 | |
| Chiesi USA, INC. | $256.96 | 2025 | Kengreal |
| Philips North America LLC | $254.42 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $194.34 | 2022 | |
| Edwards Lifesciences Corporation | $184.78 | 2022 | |
| Reflow Medical INC | $101.31 | 2024 | |
| Avinger INC. | $99.20 | 2023 | Pantheris |
| Medtronic Vascular, INC. | $85.80 | 2019 | |
| Zoll Circulation INC | $85.47 | 2022 | |
| Biosense Webster, INC. | $60.49 | 2024-2025 | N/A, Nuvision Ice Catheter, Soundstar |
| Opsens INC. | $40.00 | 2021 | |
| Inari Medical, INC. | $36.70 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Novartis Pharmaceuticals Corporation | $35.12 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.72 | 2025 | Jardiance |
| Pfizer INC. | $18.96 | 2025 | |
| Stryker Corporation | $18.27 | 2021 | |
| Amgen INC. | $15.02 | 2024 | Repatha |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rhian Davies listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.